Safety alert against four medical products

abu dhabi — The Ministry of Health and Prevention (Mohap) has alerted consumers and healthcare professionals against the use of four pharmaceutical products for the treatment of neurological, respiratory and underactive thyroid disease due to possible microbial contamination and contagious infection.

A warning against homoeopathic drug products Neuroveen, a natural relief of neuralgia nerve pain; Respitrol, relief for safe, temporary relief of chest tightness, shortness of breath, wheezing and coughing; Thyroveev, a homoeopathic remedy for underactive thyroid or hypothyroidism; and Compulsin, a natural relief of obsessive thoughts and compulsive urges, was issued by Dr Amin Hussein Al Amiri, assistant under-secretary for public health policy and licensing at the ministry and chairman of the supreme pharmacovigilance committee, to medical zones, public and private hospitals, doctors and pharmacists.

Hellolife Inc. issued a voluntary worldwide recall of Neuroveen, Respitrol, Thyroveev and Compulsin due to possible microbial contamination with the knowledge of and in cooperation with the US Food and Drug Administration.

The circular said these products are distributed worldwide via wholesale, retail and online sales and the safety alert was motivated according to a warning letter from the FDA and the manufacturer Hellolife.

The manufacturer has said that the administration or use of products with microbial contamination could potentially result in increased infections that may require medical intervention, and could result in infections.

The ministry warned the public not to purchase any unregistered pharmaceutical products or food additives from bogus pharmacies on the Internet and social media. —